deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00778908

Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Late-Course Accelerated Hyperfractionated IMRT Versus Conventionally Fractionated IMRT in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: A Prospective Randomized Clinical Trial

Sponsor: Guangxi Medical University

Conditions Nasopharyngeal Carcinoma
Interventions Concomitant cisplatin chemotherapy Conventionally fractionated IMRT Late-course accelerated hyperfractionated IMRT
Updated 6 times since 2017 Last updated: Aug 17, 2012 Started: Jan 31, 2008 Primary completion: Jan 31, 2011 Completion: Dec 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Nasopharyngeal Carcinoma and is currently completed. Guangxi Medical University leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotCompleted~Jun 2025 – present · 10 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Jun 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Jun 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Guangxi Medical University
  • Guangxi Sci-Tech Office
  • People's Hospital of Guangxi Zhuang Autonomous Region
Data source: Guangxi Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations